Michael Matson
Stock Analyst at Needham
(4.20)
# 1,515
Out of 5,044 analysts
1609
Total ratings
48.3%
Success rate
5.8%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NEO NeoGenomics | Reiterated: Buy | $19 → $22 | $16.35 | +34.56% | 40 | Oct 6, 2026 | |
| SYK Stryker | Reiterated: Buy | $418 | $277.33 | +50.72% | 75 | Oct 6, 2026 | |
| INGN Inogen | Reiterated: Buy | $12 | $6.18 | +94.17% | 88 | Oct 1, 2026 | |
| LUCD Lucid Diagnostics | Reiterated: Buy | $3 | $0.638 | +370.22% | 34 | Oct 1, 2026 | |
| MMSI Merit Medical Systems | Reiterated: Buy | $101 | $87.21 | +15.81% | 70 | Sep 29, 2026 | |
| TMDX TransMedics Group | Rated: Buy | $106 | $77.87 | +36.12% | 31 | Sep 22, 2026 | |
| MDT Medtronic | Reiterated: Buy | $114 | $88.48 | +28.84% | 100 | Sep 17, 2026 | |
| VCYT Veracyte | Reiterated: Buy | $69 | $45.23 | +52.55% | 37 | Sep 15, 2026 | |
| ATRC AtriCure | Reiterated: Buy | $45 → $64 | $55.81 | +14.67% | 104 | Sep 2, 2026 | |
| ENOV Enovis | Reiterated: Buy | $52 | $17.69 | +193.95% | 19 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $159 → $170 | $125.12 | +35.87% | 72 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $118.69 | - | 48 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $3.37 | +167.06% | 37 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $58 | $53.81 | +7.79% | 1 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $21.26 | +106.96% | 61 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $165 → $187 | $160.32 | +16.64% | 14 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $230.05 | - | 96 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $86 → $95 | $61.67 | +54.05% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $16.00 | - | 40 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $214.40 | - | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $14.21 | - | 42 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $35 | $21.65 | +61.66% | 52 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 → $93 | $76.39 | +21.74% | 87 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $89.14 | - | 89 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $44.42 | - | 83 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 | $42.73 | +33.40% | 128 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $319.40 | - | 24 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.03 | n/a | 2 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $82 | $74.65 | n/a | 22 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $19.37 | n/a | 1 | Mar 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.67 | n/a | 50 | Dec 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.11 | n/a | 10 | Nov 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $10.36 | n/a | 1 | Nov 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $636 | $423.96 | n/a | 1 | Apr 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $15 → $14 | $9.36 | n/a | 4 | Apr 9, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $9.17 | n/a | 1 | Apr 17, 2009 |
NeoGenomics
Oct 6, 2026
Reiterated: Buy
Price Target: $19 → $22
Current: $16.35
Upside: +34.56%
Stryker
Oct 6, 2026
Reiterated: Buy
Price Target: $418
Current: $277.33
Upside: +50.72%
Inogen
Oct 1, 2026
Reiterated: Buy
Price Target: $12
Current: $6.18
Upside: +94.17%
Lucid Diagnostics
Oct 1, 2026
Reiterated: Buy
Price Target: $3
Current: $0.638
Upside: +370.22%
Merit Medical Systems
Sep 29, 2026
Reiterated: Buy
Price Target: $101
Current: $87.21
Upside: +15.81%
TransMedics Group
Sep 22, 2026
Rated: Buy
Price Target: $106
Current: $77.87
Upside: +36.12%
Medtronic
Sep 17, 2026
Reiterated: Buy
Price Target: $114
Current: $88.48
Upside: +28.84%
Veracyte
Sep 15, 2026
Reiterated: Buy
Price Target: $69
Current: $45.23
Upside: +52.55%
AtriCure
Sep 2, 2026
Reiterated: Buy
Price Target: $45 → $64
Current: $55.81
Upside: +14.67%
Enovis
Sep 1, 2026
Reiterated: Buy
Price Target: $52
Current: $17.69
Upside: +193.95%
Aug 25, 2026
Rated: Buy
Price Target: $159 → $170
Current: $125.12
Upside: +35.87%
Aug 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $118.69
Upside: -
Aug 18, 2026
Reiterated: Buy
Price Target: $9
Current: $3.37
Upside: +167.06%
Aug 17, 2026
Initiated Coverage: Buy
Price Target: $58
Current: $53.81
Upside: +7.79%
Aug 7, 2026
Reiterated: Buy
Price Target: $44
Current: $21.26
Upside: +106.96%
Aug 7, 2026
Rated: Buy
Price Target: $165 → $187
Current: $160.32
Upside: +16.64%
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $230.05
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: $86 → $95
Current: $61.67
Upside: +54.05%
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $16.00
Upside: -
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $214.40
Upside: -
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.21
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: $30 → $35
Current: $21.65
Upside: +61.66%
Aug 5, 2026
Reiterated: Buy
Price Target: $81 → $93
Current: $76.39
Upside: +21.74%
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $89.14
Upside: -
Jul 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $44.42
Upside: -
Jul 29, 2026
Reiterated: Buy
Price Target: $57
Current: $42.73
Upside: +33.40%
Feb 25, 2026
Reiterated: Hold
Price Target: n/a
Current: $319.40
Upside: -
Apr 5, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.03
Upside: n/a
May 5, 2021
Reiterated: Buy
Price Target: $65 → $82
Current: $74.65
Upside: n/a
Mar 18, 2020
Reiterated: Buy
Price Target: $27
Current: $19.37
Upside: n/a
Dec 6, 2018
Rated: Hold
Price Target: n/a
Current: $4.67
Upside: n/a
Nov 11, 2016
Reiterated: Buy
Price Target: n/a
Current: $2.11
Upside: n/a
Nov 6, 2015
Reiterated: Buy
Price Target: $1
Current: $10.36
Upside: n/a
Apr 19, 2013
Reiterated: Buy
Price Target: $636
Current: $423.96
Upside: n/a
Apr 9, 2013
Upgraded: Buy
Price Target: $15 → $14
Current: $9.36
Upside: n/a
Apr 17, 2009
Downgraded: Sell
Price Target: n/a
Current: $9.17
Upside: n/a